Discovery of a highly potent and selective Bruton's tyrosine kinase inhibitor avoiding impairment of ADCC effects for B-cell non-Hodgkin lymphoma.
Juan LiuQianmao LiangAoli WangFengming ZouZiping QiKailin YuQingwang LiuCheng ChenJing LiuQing-Song LiuPublished in: Signal transduction and targeted therapy (2020)
Keyphrases